2022 was a year of uncertainty for pharma and market access. So we figured it was a good time to ask  payer executives for their thoughts on the subject -- and gain some insights from their responses. 

Susan Weber, today's guest on The IDI, wrote and supervised the survey. She's the best person to interpret the findings and draw some lessons for market access professionals. 

Connect with Susan Weber on LinkedIn.

Follow Valuate on LinkedIn or visit us at ValuateHealth.com.